|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
Journal Archive
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Hematologic malignancy
Outcomes in Refractory Diffuse Large B-Cell
Lymphoma
: Results from Two Prospective Korean Cohorts
Jun Ho Yi, Seong Hyun Jeong, Seok Jin Kim, Dok Hyun Yoon, Hye Jin Kang, Youngil Koh, Jin Seok Kim, Won-Sik Lee, Deok-Hwan Yang, Young Rok Do, Min Kyoung Kim, Kwai Han Yoo, Yoon Seok Choi, Whan Jung Yun, Yong Park, Jae-Cheol Jo, Hyeon-Seok Eom, Jae-Yong Kwak, Ho-Jin Shin, Byeong Bae Park, Seong Yoon Yi, Ji-Hyun Kwon, Sung Yong Oh, Hyo Jung Kim, Byeong Seok Sohn, Jong Ho Won, Dae-Sik Hong, Ho-Sup Lee, Gyeong-Won Lee, Cheolwon Suh, Won Seog Kim
Cancer Res Treat.
2023;55(1):325-333. Published online April 22, 2022 DOI:
https://doi.org/10.4143/crt.2022.008
Cited By 1
A New Prognostic Index for Extranodal Natural Killer/T-Cell
Lymphoma
:Incorporation of Serum β-2 Microglobulin to PINK
Sora Kang, Hyungwoo Cho, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Yoon Sei Lee, Chan-Sik Park, Heounjeong Go, Jooryung Huh, Jin Sook Ryu, Sang-Wook Lee, Seok Jin Kim, Won Seog Kim, Sang Eun Yoon, Young Hyeh Ko, Cheolwon Suh
Cancer Res Treat.
2023;55(1):314-324. Published online March 31, 2022 DOI:
https://doi.org/10.4143/crt.2022.015
Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin’s
Lymphoma
: A Multicenter Randomized Phase II Study bythe Consortium for Improving Survival of
Lymphoma
(CISL)
Kyoung Ha Kim, Jae Hoon Lee, Mark Lee, Hoon-Gu Kim, Young Rok Do, Yong Park, Sung Yong Oh, Ho-Jin Shin, Won Seog Kim, Seong Kyu Park, Jee Hyun Kong, Moo-Rim Park, Deok-Hwan Yang, Jae-Yong Kwak, Hye Jin Kang, Yeung-Chul Mun, Jong-Ho Won
Cancer Res Treat.
2023;55(1):304-313. Published online March 30, 2022 DOI:
https://doi.org/10.4143/crt.2022.004
Circulating Tumor DNA–Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell
Lymphoma
s
Seok Jin Kim, Yeon Jeong Kim, Sang Eun Yoon, Kyung Ju Ryu, Bon Park, Donghyun Park, Duck Cho, Hyun-Young Kim, Junhun Cho, Young Hyeh Ko, Woong-Yang Park, Won Seog Kim
Cancer Res Treat.
2023;55(1):291-303. Published online March 2, 2022 DOI:
https://doi.org/10.4143/crt.2022.017
Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell
Lymphoma
Treated with R-CHOP: A Prospective Cohort Study
Seong Hyun Jeong, Seok Jin Kim, Dok Hyun Yoon, Yong Park, Hye Jin Kang, Youngil Koh, Gyeong-Won Lee, Won-Sik Lee, Deok-Hwan Yang, Young Rok Do, Min Kyoung Kim, Kwai Han Yoo, Yoon Seok Choi, Hwan Jung Yun, Jun Ho Yi, Jae-Cheol Jo, Hyeon-Seok Eom, Jae-Yong Kwak, Ho-Jin Shin, Byeong Bae Park, Shin Young Hyun, Seong Yoon Yi, Ji-Hyun Kwon, Sung Yong Oh, Hyo Jung Kim, Byeong Seok Sohn, Jong Ho Won, Se-Hyung Kim, Ho-Sup Lee, Cheolwon Suh, Won Seog Kim
Cancer Res Treat.
2022;54(4):1268-1277. Published online December 30, 2021 DOI:
https://doi.org/10.4143/crt.2021.1168
Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia during R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell
Lymphoma
Do Young Kim, Jehyun Nam, Joo-Seop Chung, Byeol Eun Jeon, Ji Hyun Lee, Jae-Cheol Jo, Sang-Woo Kim, Ho-Jin Shin
Cancer Res Treat.
2022;54(4):1256-1267. Published online December 31, 2021 DOI:
https://doi.org/10.4143/crt.2021.944
CNS cancer
Hypo-trimethylation of Histone H3 Lysine 4 and Hyper-tri/dimethylation of Histone H3 Lysine 27 as Epigenetic Markers of Poor Prognosis in Patients with Primary Central Nervous System
Lymphoma
Hoon Gi Kim, Minseok S. Kim, Young Sam Lee, Eun Hee Lee, Dae Cheol Kim, Sung-Hun Lee, Young Zoon Kim
Cancer Res Treat.
2022;54(3):690-708. Published online November 17, 2021 DOI:
https://doi.org/10.4143/crt.2021.1121
Cited By 2
Hematologic malignancy
Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell
Lymphoma
: A Retrospective Study
Yu Ri Kim, Soo-Jeong Kim, Hye Sun Lee, Soyoung Jeon, Hyunsoo Cho, Haerim Chung, Ji Eun Jang, June-Won Cheong, Yoo Hong Min, Jin Seok Kim
Cancer Res Treat.
2022;54(2):613-620. Published online August 5, 2021 DOI:
https://doi.org/10.4143/crt.2021.270
Cited By 1
Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System
Lymphoma
Sang Eun Yoon, Yeon Jeong Kim, Joon Ho Shim, Donghyun Park, Junhun Cho, Young Hyeh Ko, Woong-Yang Park, Yeung-Chul Mun, Kyoung Eun Lee, Duck Cho, Won Seog Kim, Seok Jin Kim
Cancer Res Treat.
2022;54(2):597-612. Published online July 23, 2021 DOI:
https://doi.org/10.4143/crt.2021.752
Cited By 2
Pediatric cancer
Epidemiology of Acute Leukemia among Children with Down Syndrome in Korea
Young Bae Choi, Keon Hee Yoo
Cancer Res Treat.
2022;54(2):572-578. Published online August 10, 2021 DOI:
https://doi.org/10.4143/crt.2021.368
Hematologic malignancy
Increased Risk of Diabetes after Definitive Radiotherapy in Patients with Indolent Gastroduodenal
Lymphoma
Jong Yun Baek, Do Hoon Lim, Dongryul Oh, Heerim Nam, Jae J Kim, Jun Haeng Lee, Byung-Hoon Min, Hyuk Lee
Cancer Res Treat.
2022;54(1):294-300. Published online April 1, 2021 DOI:
https://doi.org/10.4143/crt.2021.073
Cited By 1
Hematologic Malignancy
Prognostic Stratification of Patients with Burkitt
Lymphoma
Using Serum β2-microglobulin Levels
Hyung-Don Kim, Hyungwoo Cho, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Chan-Sik Park, Jooryung Huh, Jin Sook Ryu, Sang-Wook Lee, Dok-Hyun Yoon, Seok Jin Kim, Young Hyeh Ko, Won Seog Kim, Cheolwon Suh
Cancer Res Treat.
2021;53(3):847-856. Published online December 17, 2020 DOI:
https://doi.org/10.4143/crt.2020.1060
Cited By 1
Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on
18
F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic
Lymphoma
Xiaoyan Feng, Xin Wen, Ling Li, Zhenchang Sun, Xin Li, Lei Zhang, Jingjing Wu, Xiaorui Fu, Xinhua Wang, Hui Yu, Xinran Ma, Xudong Zhang, Xinli Xie, Xingmin Han, Mingzhi Zhang
Cancer Res Treat.
2021;53(3):837-846. Published online December 2, 2020 DOI:
https://doi.org/10.4143/crt.2020.123
Cited By 7
Hematologic malignancy
Differing Outcomes of Patients with High Hyperdiploidy and
ETV6
-
RUNX1
Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia
Jae Wook Lee, Seongkoo Kim, Pil-Sang Jang, Nack-Gyun Chung, Bin Cho
Cancer Res Treat.
2021;53(2):567-575. Published online October 8, 2020 DOI:
https://doi.org/10.4143/crt.2020.507
Cited By 3
Lymphoma
Prognostic Impact of Age at the Time of Diagnosis in Korean Patients with Diffuse Large B-cell
Lymphoma
in the Rituximab Era: A Single Institution Study
Hee Sang Hwang, Meejeong Kim, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh, Jooryung Huh, Heounjeong Go
Cancer Res Treat.
2021;53(1):270-278. Published online September 15, 2020 DOI:
https://doi.org/10.4143/crt.2020.626
Cited By 1
Crohn’s Disease Following Rituximab Treatment for Follicular
Lymphoma
in a Patient with Synchronous Gastric Signet Ring Cells Carcinoma: A Case Report and Literature Review
Elisabetta Cavalcanti, Raffaele Armentano, Ivan Lolli
Cancer Res Treat.
2020;52(4):1291-1295. Published online July 13, 2020 DOI:
https://doi.org/10.4143/crt.2020.406
Cited By 2
Lymphoma
Forkhead Box C1 (FOXC1) Expression in Stromal Cells within the Microenvironment of T and NK Cell
Lymphoma
s: Association with Tumor Dormancy and Activation
Ji Hae Nahm, Woo Ick Yang, Sun Och Yoon
Cancer Res Treat.
2020;52(4):1273-1282. Published online July 3, 2020 DOI:
https://doi.org/10.4143/crt.2020.032
Increasing Incidence of B-Cell Non-Hodgkin
Lymphoma
and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database
Jin Seok Kim, Yanfang Liu, Kyoung Hwa Ha, Hong Qiu, Lee Anne Rothwell, Hyeon Chang Kim
Cancer Res Treat.
2020;52(4):1262-1272. Published online May 4, 2020 DOI:
https://doi.org/10.4143/crt.2020.089
Cited By 3
A Modified NHL-BFM-95 Regimen Produces Better Outcome Than HyperCVAD in Adult Patients with T-Lymphoblastic
Lymphoma
, a Two-Institution Experience
Chun Li, Zhi-Jun Wuxiao, Xiaoqin Chen, Guanjun Chen, Yue Lu, Zhongjun Xia, Yang Liang, Hua Wang
Cancer Res Treat.
2020;52(2):573-585. Published online December 6, 2019 DOI:
https://doi.org/10.4143/crt.2019.542
Cited By 5
Detection of Targetable Genetic Alterations in Korean Lung Cancer Patients: A Comparison Study of Single-Gene Assays and Targeted Next-Generation Sequencing
Eunhyang Park, Hyo Sup Shim
Cancer Res Treat.
2020;52(2):543-551. Published online November 8, 2019 DOI:
https://doi.org/10.4143/crt.2019.305
Cited By 9
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30–Expressing Non-Hodgkin
Lymphoma
s: Results of a Multicenter, Open-Labeled Phase II Trial
Seok Jin Kim, Dok Hyun Yoon, Jin Seok Kim, Hye Jin Kang, Hye Won Lee, Hyeon-Seok Eom, Jung Yong Hong, Junhun Cho, Young Hyeh Ko, Jooryung Huh, Woo-Ick Yang, Weon Seo Park, Seung-Sook Lee, Cheolwon Suh, Won Seog Kim
Cancer Res Treat.
2020;52(2):374-387. Published online August 13, 2019 DOI:
https://doi.org/10.4143/crt.2019.198
Cited By 15
Clinical Characteristics and Treatment Outcomes of Pediatric Patients with Non-Hodgkin
Lymphoma
in East Asia
Jin Kyung Suh, Yi-Jin Gao, Jing-Yan Tang, Shiann-Tarng Jou, Dong-Tsamn Lin, Yoshiyuki Takahashi, Seiji Kojima, Ling Jin, Yonghong Zhang, Jong Jin Seo
Cancer Res Treat.
2020;52(2):359-368. Published online July 29, 2019 DOI:
https://doi.org/10.4143/crt.2019.219
Cited By 1
Diffuse Large B-Cell
Lymphoma
Arising within Ileal Neobladder: An Expanding Spectrum of Diffuse Large B-Cell
Lymphoma
Associated with Chronic Inflammation
Hyekyung Lee, Hyunbin Shin, Nae Yu Kim, Hyun Sik Park, Jinsung Park
Cancer Res Treat.
2019;51(4):1666-1670. Published online March 22, 2019 DOI:
https://doi.org/10.4143/crt.2019.022
Cited By 1
Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell
Lymphoma
of Non-upper Aerodigestive Tract: A 17-Year Single-Center Experience
Ze-Long Liu, Xi-Wen Bi, Xue-Wen Zhang, De-Xin Lei, Pan-Pan Liu, Hang Yang, Yan Gao, Yuan-Xue Jiang, Wen-Qi Jiang, Yi Xia
Cancer Res Treat.
2019;51(4):1557-1567. Published online April 1, 2019 DOI:
https://doi.org/10.4143/crt.2018.681
Cited By 3
Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT in Patients with Follicular
Lymphoma
Jin-Hua Liang, Yun-Ping Zhang, Jun Xia, Chong-Yang Ding, Wei Wu, Li Wang, Lei Cao, Hua-Yuan Zhu, Lei Fan, Tian-Nv Li, Jian-Yong Li, Wei Xu
Cancer Res Treat.
2019;51(4):1479-1487. Published online March 12, 2019 DOI:
https://doi.org/10.4143/crt.2018.649
Cited By 8
Body Cavity–Based
Lymphoma
in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of
Lymphoma
Junghoon Shin, Young Hyeh Ko, Sung Yong Oh, Dok Hyun Yoon, Jeong-Ok Lee, Jin Seok Kim, Yong Park, Ho Jin Shin, Seok Jin Kim, Jong Ho Won, Sung-Soo Yoon, Won Seog Kim, Youngil Koh, On behalf of the Consortium for Improving Survival of
Lymphoma
investigators
Cancer Res Treat.
2019;51(4):1302-1312. Published online February 14, 2019 DOI:
https://doi.org/10.4143/crt.2018.555
Cited By 5
Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer
Su-Jung Kim, Soyeon Kim, Dong-Wan Kim, Miso Kim, Bhumsuk Keam, Tae Min Kim, Yusoo Lee, Jaemoon Koh, Yoon Kyung Jeon, Dae Seog Heo
Cancer Res Treat.
2019;51(3):1231-1240. Published online December 31, 2018 DOI:
https://doi.org/10.4143/crt.2018.486
Cited By 13
Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell
Lymphoma
: A Randomized, Multicenter, Open-Label Phase 3 Trial
Xueying Li, He Huang, Bing Xu, Hongqiang Guo, Yingcheng Lin, Sheng Ye, Jiqun Yi, Wenyu Li, Xiangyuan Wu, Wei Wang, Hongyu Zhan, Derong Xie, Jiewen Peng, Yabing Cao, Xingxiang Pu, Chengcheng Guo, Huangming Hong, Zhao Wang, Xiaojie Fang, Yong Zhou, Suxia Lin, Qing Liu, Tongyu Lin
Cancer Res Treat.
2019;51(3):919-932. Published online October 2, 2018 DOI:
https://doi.org/10.4143/crt.2018.230
Cited By 7
Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin
Lymphoma
s
Seok-Jin Kim, Jiyeon Hyeon, Inju Cho, Young Hyeh Ko, Won Seog Kim
Cancer Res Treat.
2019;51(2):611-622. Published online July 20, 2018 DOI:
https://doi.org/10.4143/crt.2018.191
Cited By 47
Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular
Lymphoma
Hansang Lee, Dongryul Oh, Kyungmi Yang, Young Hyeh Ko, Yong Chan Ahn, Won Seog Kim, Seok Jin Kim
Cancer Res Treat.
2019;51(2):547-555. Published online July 10, 2018 DOI:
https://doi.org/10.4143/crt.2018.190
Cited By 9
1
2
3
4